@article{32d85ceebb2949c1b05113dae033631e,
title = "Drug-Eluting Stents for Treatment of Peripheral Artery Disease",
abstract = "Endovascular intervention is a mainstay treatment of peripheral artery disease (PAD) in addition to aggressive risk factor modification and exercise programs in patients with favorable anatomy or in those who are considered too high risk for surgical intervention. Treatment with percutaneous transluminal angioplasty (PTA) and bare metal stents (BMS) has been limited by high rates of in-stent restenosis (ISR) requiring repeat revascularization. Drug-eluting stents (DES), developed and designed to reduce ISR, offer a promising solution to the current challenges in endovascular management of PAD. Several randomized clinical trials have shown improved short- and mid-term outcomes with DES as compared with both PTA and BMS. Herein we provide an up-to-date review of the current literature on DES use in PAD.",
author = "Kazeen Abdullah and {Bou Dargham}, Bassel and Micah Steinbrecher and Bo Sun and Zhao Huiqiang and Houman Khalili and Brilakis, {Emmanouil S.} and Subhash Banerjee",
note = "Funding Information: Dr. Brilakis has received a speaker honorarium from Abbott Vascular, Asahi, Cardinal Health, Elsevier, GE Healthcare, and St. Jude Medical and research support from InfraRedx and Boston Scientific. His spouse is an employee of Medtronic. Dr. Banerjee has received a speaker honorarium from Medtronic and Gore and research grants from Boston Scientific and Merck. Kazeen Abdullah,?Bassel Bou Dargham, MD, Micah Steinbrecher, Bo Sun, MD, Zhao Huiqiang, MD and, Houman Khalili have no conflict of interest that is relevant to this manuscript. Funding Information: Conflict of interest Dr. Brilakis has received a speaker honorarium from Abbott Vascular, Asahi, Cardinal Health, Elsevier, GE Healthcare, and St. Jude Medical and research support from InfraRedx and Boston Scientific. His spouse is an employee of Medtronic. Dr. Banerjee has received a speaker honorarium from Medtronic and Gore and research grants from Boston Scientific and Merck. Kazeen Abdullah, Bassel Bou Dargham, MD, Micah Steinbrecher, Bo Sun, MD, Zhao Huiqiang, MD and, Houman Khalili have no conflict of interest that is relevant to this manuscript. Publisher Copyright: {\textcopyright} 2018, This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection.",
year = "2018",
month = jun,
day = "1",
doi = "10.1007/s40256-018-0265-4",
language = "English (US)",
volume = "18",
pages = "175--180",
journal = "American Journal of Cardiovascular Drugs",
issn = "1175-3277",
publisher = "Adis International Ltd",
number = "3",
}